TCIFF distributes grants and uses influence to fund and catalyze partners in developing countries, aiming to improve children's health, nutrition, sexual and reproductive health, deworming, and protection from exploitation. Its approach combines business-like discipline with development practice, and it emphasizes data and evidence to measure progress and share learnings publicly. It differentiates itself by a strong emphasis on grantmaking quality, cross-country expertise, and transparent learning while pursuing large-scale, lasting change. Its goal is to ensure all children survive and thrive, while promoting a climate-safe future and greater equity for girls and young women.
Work here?Claim your company
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2002
See people who can refer or advise you
FSD Africa, the UK-backed financial sector development agency, in collaboration with the UN Economic Commission for Africa (UNECA) and with support from the Children's Investment Fund Foundation (CIFF), has announced the launch of a funded technical assistance and institutional support programme for Debt Management Offices (DMOs) across the continent.
During the inaugural 2024 AVPA Conference which took place in Nairobi, Kenya this year, the African Venture Philanthropy Alliance (AVPA) announced the launch of their catalytic pooled fund (CPF) in partnership with the Children's Investment Fund Foundation (CIFF) and Prosper Africa to the sound and flair of a small fireworks display.
New York, New York - September 25, 2024 - The Children's Investment Fund Foundation (CIFF) in partnership with Prosper Africa, and in support of the African Venture Philanthropy Alliance (AVPA) is proud to announce the Catalytic Pooled Fund (CPF), a transformative collective designed to mobilize catalytic capital in Africa to drive private sector investment in social development at scale.
Cross-Border Impact Ventures (CBIV) invests in health technology companies with global growth, high return, and impact potential. Its primary focus is on medical device, diagnostic, and digital health companies based in North America and Europe that are globally relevant, including in emerging markets. Target investments include healthcare software companies with $1M - $10M in revenue, as well as companies developing technologies that require regulatory approval and have at least one product that is CE Mark or FDA approved. The Fund uses a gender lens to invest and will work with portfolio companies to improve their diversity and ensure products reach a broader audience. (Photo: Business Wire)Cross-Border Impact Ventures (CBIV) invests in health technology companies with global growth, high return, and impact potential. Its primary focus is on medical device, diagnostic, and digital health companies based in North America and Europe that are globally relevant, including in emerging markets
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2002
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs